text: <html>
          <head> <meta charset="UTF-8">
          <style>
          table, th, td {
              border: 1px solid black;
              font-size: 10px;
          }
          </style> </head>
          <body>
          <table frame="hsides" rules="groups" width="100%%">
              [html]<thead><tr><td></td><tdcolspan="2">Year ended December 31.2013</td><tdcolspan="2">Clinical Clinical Amount</td><tdcolspan="2">Significance</td><tdcolspan="2">Clinical Amount</td><tdcolspan="2">Summary</td><tdcolspan="2">Share premium</td></tr><tr><td>Retained earnings</td><td>Available - for - sale financial assets reserve</td><td>Hedging reserve</td><td>sharehold</td><td>Total reholders ’ equity</td><td>Table</td><td>( 000s )</td><td>( 000s )</td><td>Balances, January 1.2013</td><td>$ 72</td><td>112.462</td><td>$ 397</td><td>402.788</td></tr></thead><tbody><tr><td></td><tdcolspan="2">$ –</td><tdcolspan="2">$</td><tdcolspan="2">3.046</td><tdcolspan="2">$ 243</td><tdcolspan="2">$</td><tdcolspan="2">10</td></tr><tr><td>$</td><td>3.768</td><td>Net income for the yearOther comprehensive income ( loss ):</td><td>–</td><td>—</td><td>–</td><td>–</td><td>–</td><td>1.669</td><td>–</td><td>–</td><td>1.669</td><td>Defined benefit pension plans, net of tax</td></tr><tr><td>–</td><td>—</td><td>–</td><td>–</td><td>–</td><td>98</td><td>–</td><td>–</td><td>98</td><td>Available - for - sale investments, net of tax</td><td>–</td><td>–</td><td>–</td></tr><tr><td>-</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>–</td><td>–</td><td>158</td><td>-</td><td>158</td><td>Derivative instruments, net of tax</td><td>–</td><td>—</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>( 111 )</td><td>( 111 )</td><td>Total other comprehensive income ( loss )</td><td>–</td><td>—</td><td>–</td><td>–</td><td>–</td><td>98</td><td>158</td><td>( 111 )</td><td>145</td><td>Comprehensive income for the yearTransactions with shareholders, recorded directly in equity :</td></tr><tr><td>–</td><td>—</td><td>–</td><td>–</td><td>–</td><td>1.767</td><td>158</td><td>( 111 )</td><td>1.814</td><td>Repurchase / cancellation of Class B Non - Voting</td><td>shares ( note 23 )</td><td>–</td><td>–</td></tr><tr><td>( 1 )</td><td>( 591 )</td><td>–</td><td>( 21 )</td><td>–</td><td>–</td><td>( 22 )</td><td>Dividends declared</td><td>–</td><td>—</td><td>–</td><td>-</td><td>–</td></tr><tr><td>( 896 )</td><td>–</td><td>-</td><td>( 896 )</td><td>Shares issued on exercise of stock options</td><td>–</td><td>–</td><td>5</td><td>84</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>5</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total transactions with shareholders</td><td>–</td><td>—</td><td>4</td><td>( 507 )</td><td>–</td><td>( 917 )</td><td>–</td><td>–</td><td>( 913 )</td><td>Balances, December 31.2013</td><td>$ 72</td><td>112.462</td></tr><tr><td>$ 401</td><td>402.281</td><td>$ −</td><td>$</td><td>3.896</td><td>$ 401</td><td>$ ( 101 )</td><td>$</td><td>4.669</td><td>Year ended December 31.2012</td><td>Clinical Clinical Amount</td><td>Significance</td><td>Clinical Amount</td></tr><tr><td>Body shares Number of shares</td><td>Share premium</td><td>Retained earnings</td><td>available - for - sale inancial assets reserve</td><td>Hedging reserve</td><td>sharehold</td><td>Total olders ’ equity</td><td>Table</td><td>( 000s )</td><td>( 000s )</td><td>Balances, January 1.2012</td><td>$ 72</td><td>112.462</td></tr><tr><td>$ 406</td><td>412.395</td><td>$ 243</td><td>$</td><td>2.443</td><td>$</td><td>433</td><td>$ ( 25 )</td><td>$</td><td>3.572</td><td>Net income for the yearOther comprehensive income ( loss ):</td><td>–</td><td>–</td></tr><tr><td>–</td><td>–</td><td>–</td><td>1.693</td><td>–</td><td>–</td><td>1.693</td><td>Defined benefit pension plans, net of tax</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>173 )</td><td>–</td><td>–</td><td>( 173 )</td><td>Available - for - sale investments, net of tax</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>( 190 )</td><td>–</td></tr><tr><td>( 190 )</td><td>Derivative instruments, net of tax</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>–</td><td>35</td><td>35</td><td>Total other comprehensive income ( loss )</td><td>–</td></tr><tr><td>—</td><td>–</td><td>–</td><td>–</td><td>( 173 )</td><td>( 190 )</td><td>35</td><td>( 328 )</td><td>Comprehensive income for the year</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>–</td><td>1.520</td><td>( 190 )</td><td>35</td><td>1.365</td><td>Transactions with shareholders, recorded directly in equity :</td><td>Repurchase of Class B Non - Voting shares</td><td>( note 23 )</td><td>–</td><td>—</td><td>( 10 )</td><td>( 9.637 )</td><td>( 243 )</td></tr><tr><td>( 97 )</td><td>–</td><td>–</td><td>( 350 )</td><td>Dividends declared</td><td>–</td><td>–</td><td>–</td><td>-</td><td>–</td><td>( 820 )</td><td>–</td><td>–</td></tr><tr><td>( 820 )</td><td>Shares issued on exercise of stock options</td><td>–</td><td>–</td><td>1</td><td>30</td><td>–</td><td>–</td></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr></tbody>
          </table> </body> </html>